Health State Utility Mapping of Rimegepant for the Preventive Treatment of Migraine: Double-Blind Treatment Phase and Open Label Extension (BHV3000-305)

INTRODUCTION: The objectives of this study were to (1) report long-term health-related quality of life (HRQoL) outcomes among patients using rimegepant preventatively in BHV3000-305 (NCT03732638) open-label extension (OLE) and (2) map Migraine-Specific Quality of Life questionnaire version 2.1 (MSQv...

Descripción completa

Detalles Bibliográficos
Autores principales: Powell, Lauren C., L’Italien, Gilbert, Popoff, Evan, Johnston, Karissa, O’Sullivan, Fiona, Harris, Linda, Croop, Robert, Coric, Vladimir, Lipton, Richard B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9898331/
https://www.ncbi.nlm.nih.gov/pubmed/36417057
http://dx.doi.org/10.1007/s12325-022-02369-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9898331/
https://www.ncbi.nlm.nih.gov/pubmed/36417057
http://dx.doi.org/10.1007/s12325-022-02369-x

Ejemplares similares